L-Tyrosine

Updated September 29, 2026 · By Sophie Callahan

What is L-Tyrosine?

L-Tyrosine is a non-essential amino acid — the body synthesizes it from phenylalanine (an essential amino acid), and it is also obtained from dietary protein sources including cheese, soybeans, beef, lamb, pork, fish, chicken, nuts, eggs, and whole grains. Its primary metabolic significance is as the starting point for catecholamine synthesis: L-Tyrosine is converted to L-DOPA by tyrosine hydroxylase, then to dopamine, norepinephrine, and finally epinephrine — a cascade that produces three of the most important neurotransmitters for alertness, motivation, focus, and stress response.

How it works

L-Tyrosine's cognitive effects operate through a 'precursor loading' mechanism. Under normal conditions, tyrosine hydroxylase — the rate-limiting enzyme in catecholamine synthesis — operates well below its maximum capacity, so adding more tyrosine substrate has limited effect. However, under conditions of stress, sleep deprivation, multitasking, or high cognitive demand, catecholamine turnover increases dramatically, and the available tyrosine pool can become rate-limiting. In these conditions, supplemental tyrosine provides additional substrate to maintain neurotransmitter synthesis. A 2015 review by Jongkees et al. summarized this as: benefits are most clearly demonstrated under conditions of depleted neurotransmitter function, and limited under normal resting conditions. In the context of tinnitus, the theoretical rationale is that dopamine and norepinephrine play roles in auditory attention and neural signal processing, but no published studies have directly tested this connection.

What the evidence says

L-Tyrosine has been studied primarily for cognitive performance under stress, including military stress scenarios, cold exposure, sleep deprivation, and multitasking demands. The evidence for auditory or tinnitus-specific applications is theoretical, based on catecholamines' role in neural signaling rather than direct clinical trials.

• Tyrosine supplementation benefits cognition under stress and depleted neurotransmitter conditions. — A 2015 review evaluating the effects of tyrosine supplementation on cognitive function in both clinical and healthy populations under stress or cognitive demands, finding benefits most clearly when neurotransmitter function is depleted. (2015 review (Jongkees et al.))
• Tyrosine reduced the adverse effects of environmental stress in human subjects. — A study showing that treatment with tyrosine significantly decreased symptoms, adverse moods, and performance impairments in subjects exposed to cold and hypoxia stress conditions. (1989 stress study)
• Tyrosine improved cognitive task performance 1 hour after administration under stress conditions. — A controlled trial finding that tyrosine improved performance on two cognitive tasks that were highly sensitive to stress, with effects appearing approximately one hour after administration. (1994 cognitive study)

Effective dosage

Acute stress studies typically use high single doses of 100–150 mg/kg body weight — approximately 7–10 g for a 70 kg adult — administered 60–90 minutes before the stressor. Daily supplemental doses in nootropic formulas are typically 500–2,000 mg/day, which is a substantially lower range than the acute stress protocol.

N-Acetyl-L-Tyrosine (NALT) is a more water-soluble form sometimes used in liquid formulas, though its bioavailability relative to free-form L-Tyrosine is debated, with some evidence suggesting lower conversion to tyrosine in vivo.

In multi-ingredient formulas — especially spray formats with limited total active volume — achieving even the supplemental range of 500 mg is challenging when the formula space is shared across multiple compounds.

Safety and interactions

L-Tyrosine is generally recognized as safe (GRAS) at supplemental doses. Side effects are uncommon at typical doses (500–2,000 mg/day) but can include nausea, headache, heartburn, and joint pain at higher doses.

Drug interactions: L-Tyrosine should be used cautiously with MAO inhibitors (phenelzine, tranylcypromine, selegiline) — the combination can cause dangerous spikes in tyramine and catecholamines, potentially leading to hypertensive crisis. May interact with thyroid medications (levothyroxine), as tyrosine is also a precursor to thyroid hormones. Individuals with hyperthyroidism (Graves' disease) should avoid supplementation. May potentiate stimulant medications (amphetamines, methylphenidate). Not recommended for individuals with melanoma, as tyrosine is also a precursor to melanin.